Dental and Medical Problems

Dent Med Probl
Impact Factor (IF 2024) – 3.9
Journal Citation Indicator (JCI 2024) - 1.36
Scopus CiteScore (2024) – 5.0
Index Copernicus Value (ICV 2023) – 181.00
MNiSW – 70 pts
ISSN 1644-387X (print)
ISSN 2300-9020 (online)
Periodicity – bimonthly


 

Download original text (EN)

Dental and Medical Problems

2011, vol. 48, nr 3, July-September, p. 319–324

Publication type: original article

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

The Molecular Prognosis on Bone Osteolysis in Epulides

Molekularne prognozowanie osteolizy kości w nadziąślakach

Iwona Niedzielska1,, Bartłomiej Mrowiec2,

1 Department of Maxillofacial Surgery, Medical University of Silesia, Poland

2 Dental Practice “Polmedico”

Abstract

Background. Epuli are the most frequent gingival tumours. The lesions are often associated with bone osteolysis which necessitates more extensive surgery or removal of tumour-adjacent teeth. Recurrence, related to non-radical tumour excision, is also common. No literature data have been found concerning molecular markers responsible for the processes of osteolysis and recurrence.
Objectives. The aim of the study is molecular prognosis of bone osteolysis in epuli patients.
Material and Methods. Molecular investigations by RT-PCR were carried out on 210 biopsies collected from 70 epulus lesions. Depending on the diagnosis of bone osteolysis/lesion recurrence, expression of genes, i.e., BCL-2, BAX, H3 histone, IFNγ and its IFNγR1, IFNγR2 receptors was investigated.
Results. Recurrence and osteolysis were observed when IFNγR1/IFNγR2 quotient < 0.5. Apoptosis and proliferation genes expression did not show any significant changes.
Conclusion. When IFNγR1/IFNγR2 < 0.5, recurrence and bone osteolysis can be predicted in epuli patients.

Streszczenie

Wprowadzenie. Nadziąślaki należą do grupy najczęściej spotykanych guzów dziąsłowych jamy ustnej. Zmianie często towarzyszy osteoliza kości, która wymaga rozległego zabiegu chirurgicznego lub usunięcia guza razem z sąsiadującym zębem. Często dochodzi do nawrotu związanego z nieradykalnym wycięciem guza. W piśmiennictwie brakuje doniesień na temat molekularnych markerów odpowiedzialnych za osteolizę i nawrót w przebiegu nadziąślaków.
Cel pracy. Propozycja prognozowania osteolizy kości w przebiegu nadziąślaków.
Materiał i metody. Badania molekularne z użyciem RT-PCR były prowadzone na podstawie pobranych 210 badań histopatologicznych z 70 nadziąślaków. W zależności od stwierdzanej osteolizy kości/zmian nawrotowych oceniano ekspresję genów, np. BCL-2 BAX, histon H3, IFNγ i jego receptorów IFNγR1, IFNγR2.
Wyniki. Nawrót i osteolizę obserwowano, gdy iloraz IFNγR1/IFNγR2 był mniejszy od 0,5. Nie stwierdzono istotnych zmian w ekspresji genów odpowiedzialnych za apoptozę i proliferację.
Wnioski. Gdy IFNγR1/IFNγR2 < 0,5, można przewidywać nawrót i osteolizę kości u osób z nadziąślakami.

Key words

epulus, RT-PCR, IFNγR1, IFNγR2, IFNγ

Słowa kluczowe

nadziąślak, RT-PCR, IFNγR1, IFNγR2, IFNγ

References (27)

  1. Eronat N., Aktug M., Giinbay T., Unal T.: Peripheral giant cell granuloma: three case reports. J. Clin. Pediatr. Dent. 2000, 24, 245–248.
  2. Flaitz C.M.: Peripheral giant cell granuloma: a potentially aggressive lession in children. Pediatr. Dent. 2000, 22, 232–233.
  3. Hattowska H.: Carcinoma oral cavity (in Polish). Sanmedia, Warsaw 1994.
  4. Pandofli P.J., Felefli S., Flaitz C.M., Johnson J.V.: An aggressive peripheral giant cell granuloma in a child. J. Clin. Padiatr. Dent. 1999, 23, 353–355.
  5. Giansanti J.S., Waldron C.A.: Peripheral giant cell granuloma: review of 720 cases. J. Oral Surg. 1969, 27, 787–791.
  6. Mighell A.J., Robinson P.A., Hume W.J.: Peripheral giant cell granuloma: a clinical study of 77 cases from 62 patients and literature review. Oral Dis. 1995, 1, 12–19.
  7. Bhaskar S.N., Jacoway J.R.: Peripheral fibroma and peripheral fibroma with calcification. J. Am. Dent. Ass. 1966, 73, 1312–1320.
  8. Eversole L.R, Rovin S.: Diagnosis of gingival tumefactions. Periodontol. 1973, 44, 485.
  9. Katsikeris N., Kakarantza-Angelopoulou E., Angelopoulos A.P.: Peripheral giant cell granuloma. Clinicopathologic study of 224 new cases and review of 956 reported cases. Int. J. Oral Maxillofac. Surg. 1988, 17, 94–99.
  10. Mighell A.J., Robinson P.A, Hume W.J.: Histochemical and immunohistochemical localisation of elastic system fibres in focal reactive overgrowths of oral mucosa. J. Oral Pathol. Med. 1997, 26, 153–158.
  11. Kryst L.: Maxillofacial surgery (in Polish). PZWL, Warsaw 1993.
  12. Stolovitzky J.P., Charles A.W., McConnel F.M.: Giant cell lesions of the maxilla and paranasal sinuses. Head Neck 1994, 6, 144–148.
  13. Shafer W.G., Hine M.K., Levy B.M.: A textbook of oral pathology. Saunders, Philadelphia 1963, 119.
  14. Dahl E.C., Rhyne R.R, Correll R.W, Craig R.M.: Exophytic lesion of the maxillary gingiva. JADA 1981, 102, 62–63.
  15. Januszewicz. J., Reczyk J.: The clinic and the pathology of epulus (in Polish). J. Stomatol. 1968, 21 507–512.
  16. Hattowska H., Stelińska A.: The cytologic diagnostics of epulus. J. Stomatol. 1964, 855–860.
  17. Baxter G.R.: Study of mmyeloid epulis and its relationship to myeloid sarcoma of the long bones. Br. Dent. J. 1930, 51, 49–54.
  18. Dunning H.S.: Cysts and tumors of the jaws. JADA 1924, 11, 312.
  19. Harward J.R.: Malignant giant-cell tumor of the mandible; report of case. J. Oral Surg. 1959, 17, 75.
  20. Carvallo M.: Quatre cas d’epulis traites par I’acide trichloracetique. Rev. Stomatol. 1952, 53, 330–334.
  21. Jacquet E.: La fibrogenese dans la therapeutique des epulis. These Med., Toulouse 1973.
  22. Abbravanel P., Abravanel J., Apap G.: Le traitement medical de I’epulis par penicillinotherapie en injection locale. Actual. Odonstomatol. 1990, 44, 437–466.
  23. Body J.J., Jortay A.M., de Jager R., Ardichvili D.: Treatment with steroids of a giant cell granuloma of the maxilla. J. Surg. Oncol. 1981, 16, 7–13.
  24. Khafif A., Krempl G., Medina J.E.: Treatment of giant cell granuloma of the maxilla with intralesional injection of steroid. Head Neck 2000, 22, 822–825.
  25. Littler B.O.: Central giant cell granuloma of the jaw – a hormonal influence. Br. J. Oral Surg. 1979, 17, 43–46.
  26. Gowan D.A.: Central giant cell tumor of mandible occuring in pregnancy. Br. J. Oral Surg. 1979, 17, 47–51.
  27. O’Regan, Gibb D.H., Odell E.W.: Rapid growth of giant cell granuloma in pregnancy treated with calcitonin. Oral Surg. Oral Med. Oral Pathol. 2001, 92, 532–538.
© Wroclaw Medical University